Sectors
CLYM
Climb Bio, Inc.
10.94
2 x 9.05
2 x 16.06
bid
ask
-
0.13
1.17%
2 @ 07:04 AM
11.05 +0.11 (1.01%)
| Ytd | 173.50% | |
| 1y | 436.27% |
10.73
day range
11.29
1.54
52 week range
18.33
| Open | 11.29 | Prev Close | 11.07 | Low | 10.73 | High | 11.29 | Mkt Cap | 628.35M |
| Vol | 1.58M | Avg Vol | 1.41M | EPS | -0.82 | P/E | N/A | Forward P/E | -16.92 |
| Beta | -0.04 | Short Ratio | 5.77 | Inst. Own | 105.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 14.07 | 200-d Avg | 9.78 | 1yr Est | 22.86 |
| Income Statement | |||
| Operating Expenses | 15.36M | ||
| Research and Development Expense | 9.71M | ||
| Selling, General and Administrative Expense | 5.65M | ||
| Operating Income | -15.36M | ||
| Net Income | -13.50M | ||
| Net Income Common Stock | -13.50M | ||
| Net Income Common Stock (USD) | -13.50M | ||
| Consolidated Income | -13.50M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -13.50M | ||
| Earning Before Interest & Taxes (USD) | -13.50M | ||
| Weighted Average Shares | 76.15M | ||
| Weighted Average Shares Diluted | 76.15M | ||
| Balance Sheet | |||
| Cash and Equivalents | 44.11M | ||
| Cash and Equivalents (USD) | 44.11M | ||
| Investments | 195.11M | ||
| Investments Current | 139.02M | ||
| Investments Non-Current | 56.10M | ||
| Current Assets | 186.64M | ||
| Property, Plant & Equipment Net | 1.91M | ||
| Total Assets | 246.29M | ||
| Debt Current | 501.00K | ||
| Total Debt | 1.31M | ||
| Current Liabilities | 5.93M | ||
| Debt Non-Current | 813.00K | ||
| Total Liabilities | 6.75M | ||
| Accumulated Retained Earnings (Deficit) | -316.95M | ||
| Accumulated Other Comprehensive Income | -67.00K | ||
| Shareholders Equity | 239.55M | ||
| Shareholders Equity (USD) | 239.55M | ||
| Assets Non-Current | 59.66M | ||
| Total Debt (USD) | 1.31M | ||
| Liabilities Non-Current | 813.00K | ||
| Trade and Non-Trade Payables | 1.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 32.00K | ||
| Net Cash Flow from Financing | 103.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 35.89M | ||
| Capital Expenditure | -260.00K | ||
| Issuance (Purchase) of Equity Shares | 103.70M | ||
| Net Cash Flow from Investing | -57.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -57.00M | ||
| Net Cash Flow from Operations | -10.55M | ||
| Share Based Compensation | 1.48M | ||